Menu

    NADAL COVID-19 IgG/IgM Test

    Description:

    Intended Use:

    The NADAL® COVID-19 IgG / IgM Test is a lateral flow chromatographic immunoassay for the qualitative detection of anti-SARS-CoV-2 IgG and IgM in human whole blood, serum or plasma specimens.

    Benefits at a glance:

    • Optimized testing process
    • High specificity and sensitivity
    • Fast and reliable results in just 15 minutes
    • Storage at room temperature
    • No cross-reactivity with antibodies against a variety of infectious diseases

    Test Principle:

    Anti-human IgM are pre-coated onto the test line region ‘IgM’ and anti-human IgG are pre-coated onto the test line region ‘IgG’ of the membrane. During testing, the specimen reacts with SARS-CoV-2 antigens which are conjugated to coloured particles. The mixture then migrates along the membrane chromatographically by capillary action and reacts with the anti-human IgM and anti-human IgG in the test line region ‘IgM’ and ‘IgG’ of the membrane. The presence of a red line in the test line region ‘IgM’ and/or ‘IgG’ indicates a positive result. The absence of a red line in the test line region ‘IgM’ and/or ‘IgG’ indicates a negative result.

    Specimen collection and test procedure:

    1. Specimen collection- can be used as capillary or venous blood, serum or plasma
    2. Add a certain amount of sample to the test well
    3. Add 2 drops of buffer
    4. Interpret results after 15 minutes

    Contents:

    ① Test cassettes (individually packaged)

    ② Disposable capillary pipettes

    ③ Buffer tube

    ④ Package insert


    Performance characteristics:

    • Sensitivity - 93.7% (IgM), 98.8% (IgG)
    • Specificity - 99.1% (IgM), 98.7% (IgG)
    • CE-IVD certificated
    Cat. No.: 243003N-25
    Package: 25 pcs.


    Add to
    inquiries


    Files for download:
    IFU - NADAL COVID-19 IgG/IgM Test - BG
    IFU - NADAL COVID-19 IgG/IgM - EN